Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $3.89 and last traded at $3.88, with a volume of 2500599 ...

The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic ...

In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...

Another drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled syringe and pen injector formulations, which was approved in 2019 as a hypoglycaemia rescue ...

The best tech tutorials and in-depth reviews Try a single issue or save on a subscription Issues delivered straight to your ...

Grok 3 is "scary smart," according to Elon Musk, and is "an order of magnitude more powerful than Grok 2." ...

But did you know that the type of toothbrush you use can impact how clean your teeth are getting? Electric toothbrushes are becoming more affordable and easy to find, and they have several benefits.

Grok 3 is rolling out today starting with Premium Plus subscribers on X. Additionally, a new subscription plan called Super ...

Learn how to invest in stocks, including how to select a brokerage account and research stock market investments. Many, or all, of the products featured on this page are from our advertising ...

4. Use a Topical Treatment You might consult a healthcare provider about starting Rogaine (minoxidil), a topical treatment, for hair loss. Of note: Rogaine does not treat baldness or receding ...

Learn how interest rates affect the economy. One good solution for beginners is to use a robo-advisor to formulate an investment plan that meets your risk tolerance and financial goals.

Musk's artificial intelligence startup, xAI, introduced its latest AI model, Grok 3, on Tuesday, claiming it surpasses offerings from OpenAI and China's DeepSeek in key performance areas such as ...